nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—CYP2C19—Ifosfamide—testicular cancer	0.0825	0.36	CbGbCtD
Atomoxetine—CYP3A4—Ifosfamide—testicular cancer	0.0399	0.174	CbGbCtD
Atomoxetine—CYP2D6—Vinblastine—testicular cancer	0.0333	0.145	CbGbCtD
Atomoxetine—CYP3A4—Vinblastine—testicular cancer	0.0211	0.0923	CbGbCtD
Atomoxetine—CYP2D6—Doxorubicin—testicular cancer	0.0204	0.0892	CbGbCtD
Atomoxetine—CYP3A4—Etoposide—testicular cancer	0.019	0.0831	CbGbCtD
Atomoxetine—CYP3A4—Doxorubicin—testicular cancer	0.013	0.0567	CbGbCtD
Atomoxetine—Asthenia—Dactinomycin—testicular cancer	0.00143	0.00185	CcSEcCtD
Atomoxetine—Influenza—Epirubicin—testicular cancer	0.00142	0.00184	CcSEcCtD
Atomoxetine—Dysuria—Methotrexate—testicular cancer	0.00142	0.00184	CcSEcCtD
Atomoxetine—Paraesthesia—Cisplatin—testicular cancer	0.00141	0.00183	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Methotrexate—testicular cancer	0.00141	0.00183	CcSEcCtD
Atomoxetine—Tachycardia—Etoposide—testicular cancer	0.00141	0.00183	CcSEcCtD
Atomoxetine—Skin disorder—Etoposide—testicular cancer	0.0014	0.00182	CcSEcCtD
Atomoxetine—Erectile dysfunction—Methotrexate—testicular cancer	0.0014	0.00181	CcSEcCtD
Atomoxetine—Hyperhidrosis—Etoposide—testicular cancer	0.00139	0.00181	CcSEcCtD
Atomoxetine—Abdominal pain upper—Doxorubicin—testicular cancer	0.00139	0.0018	CcSEcCtD
Atomoxetine—Breast disorder—Doxorubicin—testicular cancer	0.00137	0.00178	CcSEcCtD
Atomoxetine—Anorexia—Etoposide—testicular cancer	0.00137	0.00178	CcSEcCtD
Atomoxetine—Decreased appetite—Cisplatin—testicular cancer	0.00137	0.00177	CcSEcCtD
Atomoxetine—Diarrhoea—Dactinomycin—testicular cancer	0.00136	0.00177	CcSEcCtD
Atomoxetine—Nasopharyngitis—Doxorubicin—testicular cancer	0.00136	0.00176	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00136	0.00176	CcSEcCtD
Atomoxetine—Vomiting—Bleomycin—testicular cancer	0.00136	0.00176	CcSEcCtD
Atomoxetine—Infestation NOS—Methotrexate—testicular cancer	0.00135	0.00176	CcSEcCtD
Atomoxetine—Infestation—Methotrexate—testicular cancer	0.00135	0.00176	CcSEcCtD
Atomoxetine—Depression—Methotrexate—testicular cancer	0.00135	0.00175	CcSEcCtD
Atomoxetine—Rash—Bleomycin—testicular cancer	0.00135	0.00175	CcSEcCtD
Atomoxetine—Pain—Cisplatin—testicular cancer	0.00135	0.00175	CcSEcCtD
Atomoxetine—Dermatitis—Bleomycin—testicular cancer	0.00135	0.00175	CcSEcCtD
Atomoxetine—Dysuria—Epirubicin—testicular cancer	0.00133	0.00172	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Epirubicin—testicular cancer	0.00132	0.00171	CcSEcCtD
Atomoxetine—Conjunctivitis—Methotrexate—testicular cancer	0.00132	0.00171	CcSEcCtD
Atomoxetine—Influenza—Doxorubicin—testicular cancer	0.00131	0.00171	CcSEcCtD
Atomoxetine—Pollakiuria—Epirubicin—testicular cancer	0.00131	0.0017	CcSEcCtD
Atomoxetine—Asthenia—Ifosfamide—testicular cancer	0.00131	0.0017	CcSEcCtD
Atomoxetine—Feeling abnormal—Cisplatin—testicular cancer	0.0013	0.00168	CcSEcCtD
Atomoxetine—Paraesthesia—Etoposide—testicular cancer	0.00129	0.00168	CcSEcCtD
Atomoxetine—Pruritus—Ifosfamide—testicular cancer	0.00129	0.00168	CcSEcCtD
Atomoxetine—Weight decreased—Epirubicin—testicular cancer	0.00129	0.00167	CcSEcCtD
Atomoxetine—Somnolence—Etoposide—testicular cancer	0.00128	0.00166	CcSEcCtD
Atomoxetine—Nausea—Bleomycin—testicular cancer	0.00127	0.00165	CcSEcCtD
Atomoxetine—Infestation NOS—Epirubicin—testicular cancer	0.00127	0.00164	CcSEcCtD
Atomoxetine—Infestation—Epirubicin—testicular cancer	0.00127	0.00164	CcSEcCtD
Atomoxetine—Vomiting—Dactinomycin—testicular cancer	0.00127	0.00164	CcSEcCtD
Atomoxetine—Rash—Dactinomycin—testicular cancer	0.00126	0.00163	CcSEcCtD
Atomoxetine—Decreased appetite—Etoposide—testicular cancer	0.00125	0.00163	CcSEcCtD
Atomoxetine—Diarrhoea—Ifosfamide—testicular cancer	0.00125	0.00162	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Etoposide—testicular cancer	0.00124	0.00161	CcSEcCtD
Atomoxetine—Body temperature increased—Cisplatin—testicular cancer	0.00124	0.00161	CcSEcCtD
Atomoxetine—Fatigue—Etoposide—testicular cancer	0.00124	0.00161	CcSEcCtD
Atomoxetine—Pain—Etoposide—testicular cancer	0.00123	0.0016	CcSEcCtD
Atomoxetine—Constipation—Etoposide—testicular cancer	0.00123	0.0016	CcSEcCtD
Atomoxetine—Conjunctivitis—Epirubicin—testicular cancer	0.00123	0.0016	CcSEcCtD
Atomoxetine—Dysuria—Doxorubicin—testicular cancer	0.00123	0.0016	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00122	0.00159	CcSEcCtD
Atomoxetine—Pollakiuria—Doxorubicin—testicular cancer	0.00121	0.00158	CcSEcCtD
Atomoxetine—Dizziness—Ifosfamide—testicular cancer	0.00121	0.00157	CcSEcCtD
Atomoxetine—Urinary tract disorder—Methotrexate—testicular cancer	0.0012	0.00156	CcSEcCtD
Atomoxetine—Urethral disorder—Methotrexate—testicular cancer	0.00119	0.00155	CcSEcCtD
Atomoxetine—Weight decreased—Doxorubicin—testicular cancer	0.00119	0.00154	CcSEcCtD
Atomoxetine—Sinusitis—Epirubicin—testicular cancer	0.00119	0.00154	CcSEcCtD
Atomoxetine—Feeling abnormal—Etoposide—testicular cancer	0.00119	0.00154	CcSEcCtD
Atomoxetine—Nausea—Dactinomycin—testicular cancer	0.00118	0.00153	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Etoposide—testicular cancer	0.00118	0.00153	CcSEcCtD
Atomoxetine—Infestation—Doxorubicin—testicular cancer	0.00117	0.00152	CcSEcCtD
Atomoxetine—Infestation NOS—Doxorubicin—testicular cancer	0.00117	0.00152	CcSEcCtD
Atomoxetine—Vomiting—Ifosfamide—testicular cancer	0.00116	0.00151	CcSEcCtD
Atomoxetine—Rash—Ifosfamide—testicular cancer	0.00115	0.00149	CcSEcCtD
Atomoxetine—Dermatitis—Ifosfamide—testicular cancer	0.00115	0.00149	CcSEcCtD
Atomoxetine—Urticaria—Etoposide—testicular cancer	0.00115	0.00149	CcSEcCtD
Atomoxetine—Abdominal pain—Etoposide—testicular cancer	0.00114	0.00148	CcSEcCtD
Atomoxetine—Body temperature increased—Etoposide—testicular cancer	0.00114	0.00148	CcSEcCtD
Atomoxetine—Conjunctivitis—Doxorubicin—testicular cancer	0.00114	0.00148	CcSEcCtD
Atomoxetine—Hypoaesthesia—Epirubicin—testicular cancer	0.00113	0.00147	CcSEcCtD
Atomoxetine—Asthenia—Cisplatin—testicular cancer	0.00113	0.00146	CcSEcCtD
Atomoxetine—Cardiac disorder—Methotrexate—testicular cancer	0.00113	0.00146	CcSEcCtD
Atomoxetine—Urinary tract disorder—Epirubicin—testicular cancer	0.00112	0.00146	CcSEcCtD
Atomoxetine—Urethral disorder—Epirubicin—testicular cancer	0.00112	0.00145	CcSEcCtD
Atomoxetine—Angiopathy—Methotrexate—testicular cancer	0.0011	0.00143	CcSEcCtD
Atomoxetine—Sinusitis—Doxorubicin—testicular cancer	0.0011	0.00143	CcSEcCtD
Atomoxetine—Mediastinal disorder—Methotrexate—testicular cancer	0.0011	0.00142	CcSEcCtD
Atomoxetine—Chills—Methotrexate—testicular cancer	0.00109	0.00141	CcSEcCtD
Atomoxetine—Nausea—Ifosfamide—testicular cancer	0.00108	0.00141	CcSEcCtD
Atomoxetine—Diarrhoea—Cisplatin—testicular cancer	0.00108	0.0014	CcSEcCtD
Atomoxetine—Mental disorder—Methotrexate—testicular cancer	0.00106	0.00138	CcSEcCtD
Atomoxetine—Malnutrition—Methotrexate—testicular cancer	0.00106	0.00137	CcSEcCtD
Atomoxetine—Flushing—Epirubicin—testicular cancer	0.00106	0.00137	CcSEcCtD
Atomoxetine—Cardiac disorder—Epirubicin—testicular cancer	0.00106	0.00137	CcSEcCtD
Atomoxetine—Hypoaesthesia—Doxorubicin—testicular cancer	0.00105	0.00136	CcSEcCtD
Atomoxetine—Urinary tract disorder—Doxorubicin—testicular cancer	0.00104	0.00135	CcSEcCtD
Atomoxetine—Dysgeusia—Methotrexate—testicular cancer	0.00104	0.00134	CcSEcCtD
Atomoxetine—Asthenia—Etoposide—testicular cancer	0.00103	0.00134	CcSEcCtD
Atomoxetine—Angiopathy—Epirubicin—testicular cancer	0.00103	0.00134	CcSEcCtD
Atomoxetine—Urethral disorder—Doxorubicin—testicular cancer	0.00103	0.00134	CcSEcCtD
Atomoxetine—Mediastinal disorder—Epirubicin—testicular cancer	0.00103	0.00133	CcSEcCtD
Atomoxetine—Back pain—Methotrexate—testicular cancer	0.00102	0.00133	CcSEcCtD
Atomoxetine—Chills—Epirubicin—testicular cancer	0.00102	0.00132	CcSEcCtD
Atomoxetine—Pruritus—Etoposide—testicular cancer	0.00102	0.00132	CcSEcCtD
Atomoxetine—Vomiting—Cisplatin—testicular cancer	0.001	0.0013	CcSEcCtD
Atomoxetine—Vision blurred—Methotrexate—testicular cancer	0.000997	0.00129	CcSEcCtD
Atomoxetine—Mental disorder—Epirubicin—testicular cancer	0.000997	0.00129	CcSEcCtD
Atomoxetine—Rash—Cisplatin—testicular cancer	0.000992	0.00129	CcSEcCtD
Atomoxetine—Dermatitis—Cisplatin—testicular cancer	0.000991	0.00129	CcSEcCtD
Atomoxetine—Malnutrition—Epirubicin—testicular cancer	0.00099	0.00128	CcSEcCtD
Atomoxetine—Diarrhoea—Etoposide—testicular cancer	0.000986	0.00128	CcSEcCtD
Atomoxetine—Flushing—Doxorubicin—testicular cancer	0.000977	0.00127	CcSEcCtD
Atomoxetine—Cardiac disorder—Doxorubicin—testicular cancer	0.000977	0.00127	CcSEcCtD
Atomoxetine—Flatulence—Epirubicin—testicular cancer	0.000976	0.00127	CcSEcCtD
Atomoxetine—Tension—Epirubicin—testicular cancer	0.000972	0.00126	CcSEcCtD
Atomoxetine—Dysgeusia—Epirubicin—testicular cancer	0.00097	0.00126	CcSEcCtD
Atomoxetine—Nervousness—Epirubicin—testicular cancer	0.000962	0.00125	CcSEcCtD
Atomoxetine—Back pain—Epirubicin—testicular cancer	0.000958	0.00124	CcSEcCtD
Atomoxetine—Angiopathy—Doxorubicin—testicular cancer	0.000955	0.00124	CcSEcCtD
Atomoxetine—Dizziness—Etoposide—testicular cancer	0.000953	0.00124	CcSEcCtD
Atomoxetine—Muscle spasms—Epirubicin—testicular cancer	0.000952	0.00124	CcSEcCtD
Atomoxetine—Vertigo—Methotrexate—testicular cancer	0.000951	0.00123	CcSEcCtD
Atomoxetine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000949	0.00123	CcSEcCtD
Atomoxetine—Chills—Doxorubicin—testicular cancer	0.000944	0.00123	CcSEcCtD
Atomoxetine—Nausea—Cisplatin—testicular cancer	0.000935	0.00121	CcSEcCtD
Atomoxetine—Vision blurred—Epirubicin—testicular cancer	0.000933	0.00121	CcSEcCtD
Atomoxetine—Cough—Methotrexate—testicular cancer	0.000923	0.0012	CcSEcCtD
Atomoxetine—Mental disorder—Doxorubicin—testicular cancer	0.000922	0.0012	CcSEcCtD
Atomoxetine—Convulsion—Methotrexate—testicular cancer	0.000917	0.00119	CcSEcCtD
Atomoxetine—Vomiting—Etoposide—testicular cancer	0.000917	0.00119	CcSEcCtD
Atomoxetine—Malnutrition—Doxorubicin—testicular cancer	0.000916	0.00119	CcSEcCtD
Atomoxetine—Agitation—Epirubicin—testicular cancer	0.00091	0.00118	CcSEcCtD
Atomoxetine—Rash—Etoposide—testicular cancer	0.000909	0.00118	CcSEcCtD
Atomoxetine—Dermatitis—Etoposide—testicular cancer	0.000908	0.00118	CcSEcCtD
Atomoxetine—Headache—Etoposide—testicular cancer	0.000903	0.00117	CcSEcCtD
Atomoxetine—Flatulence—Doxorubicin—testicular cancer	0.000903	0.00117	CcSEcCtD
Atomoxetine—Chest pain—Methotrexate—testicular cancer	0.000901	0.00117	CcSEcCtD
Atomoxetine—Myalgia—Methotrexate—testicular cancer	0.000901	0.00117	CcSEcCtD
Atomoxetine—Arthralgia—Methotrexate—testicular cancer	0.000901	0.00117	CcSEcCtD
Atomoxetine—Tension—Doxorubicin—testicular cancer	0.000899	0.00117	CcSEcCtD
Atomoxetine—Dysgeusia—Doxorubicin—testicular cancer	0.000897	0.00116	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000895	0.00116	CcSEcCtD
Atomoxetine—Nervousness—Doxorubicin—testicular cancer	0.00089	0.00115	CcSEcCtD
Atomoxetine—Vertigo—Epirubicin—testicular cancer	0.00089	0.00115	CcSEcCtD
Atomoxetine—Syncope—Epirubicin—testicular cancer	0.000888	0.00115	CcSEcCtD
Atomoxetine—Back pain—Doxorubicin—testicular cancer	0.000886	0.00115	CcSEcCtD
Atomoxetine—Muscle spasms—Doxorubicin—testicular cancer	0.000881	0.00114	CcSEcCtD
Atomoxetine—Palpitations—Epirubicin—testicular cancer	0.000875	0.00114	CcSEcCtD
Atomoxetine—Loss of consciousness—Epirubicin—testicular cancer	0.00087	0.00113	CcSEcCtD
Atomoxetine—Cough—Epirubicin—testicular cancer	0.000864	0.00112	CcSEcCtD
Atomoxetine—Vision blurred—Doxorubicin—testicular cancer	0.000863	0.00112	CcSEcCtD
Atomoxetine—Convulsion—Epirubicin—testicular cancer	0.000858	0.00111	CcSEcCtD
Atomoxetine—Infection—Methotrexate—testicular cancer	0.000858	0.00111	CcSEcCtD
Atomoxetine—Nausea—Etoposide—testicular cancer	0.000856	0.00111	CcSEcCtD
Atomoxetine—Nervous system disorder—Methotrexate—testicular cancer	0.000847	0.0011	CcSEcCtD
Atomoxetine—Chest pain—Epirubicin—testicular cancer	0.000843	0.00109	CcSEcCtD
Atomoxetine—Myalgia—Epirubicin—testicular cancer	0.000843	0.00109	CcSEcCtD
Atomoxetine—Arthralgia—Epirubicin—testicular cancer	0.000843	0.00109	CcSEcCtD
Atomoxetine—Agitation—Doxorubicin—testicular cancer	0.000842	0.00109	CcSEcCtD
Atomoxetine—Anxiety—Epirubicin—testicular cancer	0.00084	0.00109	CcSEcCtD
Atomoxetine—Skin disorder—Methotrexate—testicular cancer	0.000839	0.00109	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000837	0.00109	CcSEcCtD
Atomoxetine—Hyperhidrosis—Methotrexate—testicular cancer	0.000835	0.00108	CcSEcCtD
Atomoxetine—Dry mouth—Epirubicin—testicular cancer	0.000824	0.00107	CcSEcCtD
Atomoxetine—Vertigo—Doxorubicin—testicular cancer	0.000823	0.00107	CcSEcCtD
Atomoxetine—Anorexia—Methotrexate—testicular cancer	0.000823	0.00107	CcSEcCtD
Atomoxetine—Syncope—Doxorubicin—testicular cancer	0.000822	0.00107	CcSEcCtD
Atomoxetine—Palpitations—Doxorubicin—testicular cancer	0.00081	0.00105	CcSEcCtD
Atomoxetine—Loss of consciousness—Doxorubicin—testicular cancer	0.000805	0.00104	CcSEcCtD
Atomoxetine—Infection—Epirubicin—testicular cancer	0.000803	0.00104	CcSEcCtD
Atomoxetine—Cough—Doxorubicin—testicular cancer	0.0008	0.00104	CcSEcCtD
Atomoxetine—Shock—Epirubicin—testicular cancer	0.000795	0.00103	CcSEcCtD
Atomoxetine—Convulsion—Doxorubicin—testicular cancer	0.000794	0.00103	CcSEcCtD
Atomoxetine—Nervous system disorder—Epirubicin—testicular cancer	0.000793	0.00103	CcSEcCtD
Atomoxetine—Tachycardia—Epirubicin—testicular cancer	0.000789	0.00102	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000787	0.00102	CcSEcCtD
Atomoxetine—Skin disorder—Epirubicin—testicular cancer	0.000785	0.00102	CcSEcCtD
Atomoxetine—Hyperhidrosis—Epirubicin—testicular cancer	0.000781	0.00101	CcSEcCtD
Atomoxetine—Insomnia—Methotrexate—testicular cancer	0.000781	0.00101	CcSEcCtD
Atomoxetine—Chest pain—Doxorubicin—testicular cancer	0.00078	0.00101	CcSEcCtD
Atomoxetine—Arthralgia—Doxorubicin—testicular cancer	0.00078	0.00101	CcSEcCtD
Atomoxetine—Myalgia—Doxorubicin—testicular cancer	0.00078	0.00101	CcSEcCtD
Atomoxetine—Anxiety—Doxorubicin—testicular cancer	0.000777	0.00101	CcSEcCtD
Atomoxetine—Paraesthesia—Methotrexate—testicular cancer	0.000775	0.00101	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000775	0.001	CcSEcCtD
Atomoxetine—Anorexia—Epirubicin—testicular cancer	0.00077	0.000999	CcSEcCtD
Atomoxetine—Somnolence—Methotrexate—testicular cancer	0.000768	0.000996	CcSEcCtD
Atomoxetine—Dry mouth—Doxorubicin—testicular cancer	0.000763	0.00099	CcSEcCtD
Atomoxetine—Dyspepsia—Methotrexate—testicular cancer	0.00076	0.000986	CcSEcCtD
Atomoxetine—Decreased appetite—Methotrexate—testicular cancer	0.000751	0.000974	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000746	0.000967	CcSEcCtD
Atomoxetine—Fatigue—Methotrexate—testicular cancer	0.000745	0.000966	CcSEcCtD
Atomoxetine—Infection—Doxorubicin—testicular cancer	0.000743	0.000964	CcSEcCtD
Atomoxetine—Pain—Methotrexate—testicular cancer	0.000738	0.000958	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000736	0.000955	CcSEcCtD
Atomoxetine—Shock—Doxorubicin—testicular cancer	0.000736	0.000954	CcSEcCtD
Atomoxetine—Nervous system disorder—Doxorubicin—testicular cancer	0.000733	0.000951	CcSEcCtD
Atomoxetine—Insomnia—Epirubicin—testicular cancer	0.000731	0.000948	CcSEcCtD
Atomoxetine—Tachycardia—Doxorubicin—testicular cancer	0.00073	0.000947	CcSEcCtD
Atomoxetine—Skin disorder—Doxorubicin—testicular cancer	0.000726	0.000942	CcSEcCtD
Atomoxetine—Paraesthesia—Epirubicin—testicular cancer	0.000726	0.000941	CcSEcCtD
Atomoxetine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000723	0.000938	CcSEcCtD
Atomoxetine—Somnolence—Epirubicin—testicular cancer	0.000718	0.000932	CcSEcCtD
Atomoxetine—Anorexia—Doxorubicin—testicular cancer	0.000713	0.000925	CcSEcCtD
Atomoxetine—Feeling abnormal—Methotrexate—testicular cancer	0.000712	0.000923	CcSEcCtD
Atomoxetine—Dyspepsia—Epirubicin—testicular cancer	0.000711	0.000923	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000706	0.000916	CcSEcCtD
Atomoxetine—Decreased appetite—Epirubicin—testicular cancer	0.000703	0.000911	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000698	0.000905	CcSEcCtD
Atomoxetine—Fatigue—Epirubicin—testicular cancer	0.000697	0.000904	CcSEcCtD
Atomoxetine—Pain—Epirubicin—testicular cancer	0.000691	0.000897	CcSEcCtD
Atomoxetine—Constipation—Epirubicin—testicular cancer	0.000691	0.000897	CcSEcCtD
Atomoxetine—Urticaria—Methotrexate—testicular cancer	0.000686	0.00089	CcSEcCtD
Atomoxetine—Abdominal pain—Methotrexate—testicular cancer	0.000683	0.000886	CcSEcCtD
Atomoxetine—Body temperature increased—Methotrexate—testicular cancer	0.000683	0.000886	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000681	0.000884	CcSEcCtD
Atomoxetine—Insomnia—Doxorubicin—testicular cancer	0.000676	0.000877	CcSEcCtD
Atomoxetine—Paraesthesia—Doxorubicin—testicular cancer	0.000671	0.000871	CcSEcCtD
Atomoxetine—Feeling abnormal—Epirubicin—testicular cancer	0.000666	0.000864	CcSEcCtD
Atomoxetine—Somnolence—Doxorubicin—testicular cancer	0.000665	0.000862	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000661	0.000857	CcSEcCtD
Atomoxetine—Dyspepsia—Doxorubicin—testicular cancer	0.000658	0.000854	CcSEcCtD
Atomoxetine—Decreased appetite—Doxorubicin—testicular cancer	0.00065	0.000843	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000646	0.000837	CcSEcCtD
Atomoxetine—Fatigue—Doxorubicin—testicular cancer	0.000645	0.000836	CcSEcCtD
Atomoxetine—Urticaria—Epirubicin—testicular cancer	0.000642	0.000833	CcSEcCtD
Atomoxetine—Constipation—Doxorubicin—testicular cancer	0.000639	0.00083	CcSEcCtD
Atomoxetine—Pain—Doxorubicin—testicular cancer	0.000639	0.00083	CcSEcCtD
Atomoxetine—Body temperature increased—Epirubicin—testicular cancer	0.000639	0.000829	CcSEcCtD
Atomoxetine—Abdominal pain—Epirubicin—testicular cancer	0.000639	0.000829	CcSEcCtD
Atomoxetine—Asthenia—Methotrexate—testicular cancer	0.00062	0.000804	CcSEcCtD
Atomoxetine—Feeling abnormal—Doxorubicin—testicular cancer	0.000616	0.000799	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000611	0.000793	CcSEcCtD
Atomoxetine—Pruritus—Methotrexate—testicular cancer	0.000611	0.000793	CcSEcCtD
Atomoxetine—Urticaria—Doxorubicin—testicular cancer	0.000594	0.000771	CcSEcCtD
Atomoxetine—Abdominal pain—Doxorubicin—testicular cancer	0.000591	0.000767	CcSEcCtD
Atomoxetine—Body temperature increased—Doxorubicin—testicular cancer	0.000591	0.000767	CcSEcCtD
Atomoxetine—Diarrhoea—Methotrexate—testicular cancer	0.000591	0.000767	CcSEcCtD
Atomoxetine—Asthenia—Epirubicin—testicular cancer	0.00058	0.000752	CcSEcCtD
Atomoxetine—Pruritus—Epirubicin—testicular cancer	0.000572	0.000742	CcSEcCtD
Atomoxetine—Dizziness—Methotrexate—testicular cancer	0.000571	0.000741	CcSEcCtD
Atomoxetine—Diarrhoea—Epirubicin—testicular cancer	0.000553	0.000717	CcSEcCtD
Atomoxetine—Vomiting—Methotrexate—testicular cancer	0.000549	0.000712	CcSEcCtD
Atomoxetine—Rash—Methotrexate—testicular cancer	0.000544	0.000706	CcSEcCtD
Atomoxetine—Dermatitis—Methotrexate—testicular cancer	0.000544	0.000706	CcSEcCtD
Atomoxetine—Headache—Methotrexate—testicular cancer	0.000541	0.000702	CcSEcCtD
Atomoxetine—Asthenia—Doxorubicin—testicular cancer	0.000536	0.000696	CcSEcCtD
Atomoxetine—Dizziness—Epirubicin—testicular cancer	0.000534	0.000693	CcSEcCtD
Atomoxetine—Pruritus—Doxorubicin—testicular cancer	0.000529	0.000686	CcSEcCtD
Atomoxetine—Vomiting—Epirubicin—testicular cancer	0.000514	0.000667	CcSEcCtD
Atomoxetine—Nausea—Methotrexate—testicular cancer	0.000513	0.000665	CcSEcCtD
Atomoxetine—Diarrhoea—Doxorubicin—testicular cancer	0.000512	0.000664	CcSEcCtD
Atomoxetine—Rash—Epirubicin—testicular cancer	0.00051	0.000661	CcSEcCtD
Atomoxetine—Dermatitis—Epirubicin—testicular cancer	0.000509	0.00066	CcSEcCtD
Atomoxetine—Headache—Epirubicin—testicular cancer	0.000506	0.000657	CcSEcCtD
Atomoxetine—Dizziness—Doxorubicin—testicular cancer	0.000494	0.000641	CcSEcCtD
Atomoxetine—Nausea—Epirubicin—testicular cancer	0.00048	0.000623	CcSEcCtD
Atomoxetine—Vomiting—Doxorubicin—testicular cancer	0.000475	0.000617	CcSEcCtD
Atomoxetine—Rash—Doxorubicin—testicular cancer	0.000471	0.000612	CcSEcCtD
Atomoxetine—Dermatitis—Doxorubicin—testicular cancer	0.000471	0.000611	CcSEcCtD
Atomoxetine—Headache—Doxorubicin—testicular cancer	0.000468	0.000608	CcSEcCtD
Atomoxetine—Nausea—Doxorubicin—testicular cancer	0.000444	0.000576	CcSEcCtD
